#161630

BRIN-BG5 cell line

Cat. #161630

BRIN-BG5 cell line

Cat. #: 161630

Sub-type: Hybrid cell line

Organism: Rat

Tissue: Pancreas

Disease: Diabetes

Model: Transgenic

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Peter Flatt and Neville McClenaghan

Institute: Ulster University

Primary Citation: McClenaghan NH et al. 1996. J Endocrinol.;148(3):409-17 PMID: 8778219

Tool Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: BRIN-BG5 cell line
  • Research fields: Disease (not cancer)
  • Tool sub type: Hybrid cell line
  • Parental cell: RINm5F cell line
  • Organism: Rat
  • Tissue: Pancreas
  • Disease: Diabetes
  • Morphology: Epitheloid
  • Growth properties: Adherent
  • Model: Transgenic
  • Model description: Hybrid cell line formed by the electrofusion of a primary culture of NEDH rat pancreatic islets with RINm5F (a cell line derived from a NEDH rat insuliinoma)
  • Crispr: No
  • Description: A hybrid cell line formed by the electrofusion of a primary culture of NEDH rat pancreatic islets with RINm5F (a cell line derived from a NEDH rat insuliinoma). BRIN-BG5 has been shown to be tumourigenic when transplanted into a SCID mouse host. The cell line has applications in the study of pancreatic beta cell function as they showed insulin output 5–10 times greater than parent RINm5F cells
  • Application: producing pure insulin secreting cells when stimulated

Applications

  • Application: producing pure insulin secreting cells when stimulated

Handling

  • Format: Frozen
  • Growth medium: RPMI-1640 + 2mM Glutamine + 10% FCS
  • Temperature: 37° C
  • Atmosphere: 5% CO2
  • Shipping conditions: Dry Ice
  • Storage conditions: Liquid Nitrogen
  • Initial handling information: Split sub-confluent cultures (70-80%) 1:8 to 1:10 i.e. seeding at 2-4 x 104 cells/cmÂ? using 0.05% trypsin or trypsin/EDTA; 5% CO2; 37°C. Population doubling approx 28hrs. At confluence 105 cells/cmÂ? can be expected.
  • Mycoplasma free: Yes

References

  • McClenaghan NH etal. 1999. J Mol Med. 77(1):235-43 PMID: 9930971.